IMPDH1 and urinary bladder carcinoma: In summary, we have clarified the molecular mechanism by which UCA1 controls IMPDH1/2 expression via TWIST1 to change metabolite levels and promotes guanine nucleotide de novo anabolic reprogramming and bladder cancer progression (Figure 9).